Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer

Strahlentherapie und Onkologie

Volumn 188, Issue 7, 2012, Pages 551-557

  Guckenberger, M ^a   Saur, G ^a   Wehner, D ^a   Sweeney, R A ^a   Thalheimer, A ^a   Germer, C T ^a   Flentje, M ^a  

^a UNIVERSITY HOSPITAL WÜRZBURG   (Germany)

Author keywords

5 Fluorouracil; Oxaliplatin; Prognosis; Radiotherapy; Rectal neoplasms

Indexed keywords

FLUOROURACIL; OXALIPLATIN;

ABSCESS; ACUTE TOXICITY; ADULT; ADVANCED CANCER; AGED; ANASTOMOSIS LEAKAGE; ANUS SPHINCTER; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CHEMORADIOTHERAPY; CHRONIC DIARRHEA; DISEASE SEVERITY; ENTEROCUTANEOUS FISTULA; FECES INCONTINENCE; FEMALE; HUMAN; ILEUS; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NAUSEA; OVERALL SURVIVAL; POSTOPERATIVE COMPLICATION; POSTOPERATIVE HEMORRHAGE; PREOPERATIVE RADIOTHERAPY; RADIATION DOSE FRACTIONATION; RADIATION INJURY; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; SHORT COURSE THERAPY; SURGICAL INFECTION; THERAPY DELAY; TREATMENT DURATION; TUMOR LOCALIZATION; WOUND DEHISCENCE;

AGED; CHEMORADIOTHERAPY; COLECTOMY; GERMANY; HUMANS; MALE; NEOPLASM RECURRENCE, LOCAL; PREOPERATIVE CARE; PREVALENCE; RECTAL NEOPLASMS; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84862684433     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-012-0131-2     Document Type: Article

References (22)

1. Swedish Rectal Cancer Trial(1997) Improved survival with preoperative radiotherapy in resectable rectal cancer. Swedish Rectal Cancer Trial. N Engl J Med 336:980-987
2. Gijn W van, Marijnen CA, Nagtegaal ID et al (2011) Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 12:575-582
3. Sauer R, Becker H, Hohenberger W et al (2004) Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 351:1731-1740
4. Guckenberger M, Wulf J, Thalheimer A et al (2009) Prospective phase II study of preoperative short-course radiotherapy for rectal cancer with twice daily fractions of 2.9 Gy to a total dose of 29 Gy-long-term results. Radiat Oncol 4:67
5. Peeters KC, Marijnen CA, Nagtegaal ID et al (2007) The TME trial after a median follow-up of 6 years: increased local control but no survival benefit in irradiated patients with resectable rectal carcinoma. Ann Surg 246:693-701 (Pubitemid 350035641)
6. Sebag-Montefiore D, Stephens RJ, Steele R et al (2009) Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet 373:811-820
7. Bujko K, Nowacki MP, Nasierowska-Guttmejer A et al (2006) Long-term results of a randomized trial comparing preoperative short-course radiotherapy with preoperative conventionally fractionated chemoradiation for rectal cancer. Br J Surg 93:1215-1223 (Pubitemid 44547018)
8. Ngan S, Fisher R, Goldstein D et al (2010) A randomized trial comparing local recurrence (LR) rates between short-course (SC) and long-course (LC) preoperative radiotherapy (RT) for clinical T3 rectal cancer: an intergroup trial (TROG, AGITG, CSSANZ, RACS). ASCO Annual Meeting
9. Bosset JF, Collette L, Calais G et al (2006) Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 355:1114-1123 (Pubitemid 44394918)
10. Roh MS, Colangelo LH, O'Connell MJ et al (2009) Preoperative multimodality therapy improves disease-free survival in patients with carcinoma of the rectum: NSABP R-03. J Clin Oncol 27:5124-5130
11. Adam IJ, Mohamdee MO, Martin IG et al (1994) Role of circumferential margin involvement in the local recurrence of rectal cancer. Lancet 344:707-711 (Pubitemid 24281421)
12. Gunderson LL, Sargent DJ, Tepper JE et al (2002) Impact of T and N substage on survival and disease relapse in adjuvant rectal cancer: a pooled analysis. Int J Radiat Oncol Biol Phys 54:386-396 (Pubitemid 35286802)
13. Herzog U, Flue M von, Tondelli P et al (1993) How accurate is endorectal ultrasound in the preoperative staging of rectal cancer? Dis Colon Rectum 36:127-134 (Pubitemid 23057757)
14. Bipat S, Glas AS, Slors FJ et al (2004) Rectal cancer: local staging and assessment of lymph node involvement with endoluminal US, CT, and MR imaging-a meta-analysis. Radiology 232:773-783 (Pubitemid 39100263)
15. Brown G, Taylor FGM, Quirke P et al (2011) preoperative high-resolution magnetic resonance imaging can identify good prognosis stage I, II, and III rectal cancer best managed by surgery alone a prospective, multicenter, European study. Ann Surg 253:711-719
16. Lorchel F, Peignaux K, Crehange G et al (2007) Preoperative radiotherapy in elderly patients with rectal cancer. Gastroenterol Clin Biol 31:436-441 (Pubitemid 46706834)
17. Janssen-Heijnen MLG, Shahir MA, Lemmens VEPP et al (2006) Elderly patients with rectal cancer have a higher risk of treatment-related complications and a poorer prognosis than younger patients: a population-based study. Eur J Cancer 42:3015-3021 (Pubitemid 44667466)
18. Martijn H, Vulto JC (2007) Should radiotherapy be avoided or delivered differently in elderly patients with rectal cancer? Eur J Cancer 43:2301-23016
19. Boda-Heggemann J, Lohr F, Wenz F et al (2011) kV cone-beam CT-based IGRT: a clinical review. Strahlenther Onkol 187:284-291
20. Guckenberger M, Ok S, Polat B et al (2010) Toxicity after intensity-modulated, image-guided radiotherapy for prostate cancer. Strahlenther Onkol 186:535-543
21. Ghadjar P, Gwerder N, Manser P et al (2010) High-dose (80 Gy) intensity-modulated radiation therapy with daily image-guidance as primary treatment for localized prostate cancer. Strahlenther Onkol 186:687-692
22. Pinkawa M, Piroth MD, Holy R et al (2011) Combination of dose escalation with technological advances (intensity-modulated and image-guided radiotherapy) is not associated with increased morbidity for patients with prostate cancer. Strahlenther Onkol 187:479-484